These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7751742)

  • 21. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action in vitro of antibacillar drug combinations on pluriresistant strains of tubercle bacilli].
    Kreis B; Fournaud S
    Rev Tuberc Pneumol (Paris); 1966 Apr; 30(4):445-60. PubMed ID: 4958256
    [No Abstract]   [Full Text] [Related]  

  • 23. Bactericidal activities of disinfectants against vancomycin-resistant enterococci.
    Sakagami Y; Kajimura K
    J Hosp Infect; 2002 Feb; 50(2):140-4. PubMed ID: 11846542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counts of viable tubercle bacilli in sputum related to smear and culture gradings.
    Allen BW; Mitchison DA
    Med Lab Sci; 1992 Jun; 49(2):94-8. PubMed ID: 1487984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1979 Feb; 54(2):89-92. PubMed ID: 108446
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sulfa-resistant tubercle bacilli isolated from the sputum of tuberculous patients].
    Ogawa M
    Saishin Igaku; 1966 Jul; 21(7):1592-5. PubMed ID: 4961192
    [No Abstract]   [Full Text] [Related]  

  • 28. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues.
    McCune RM; Feldmann FM; Lambert HP; McDermott W
    J Exp Med; 1966 Mar; 123(3):445-68. PubMed ID: 4957010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
    Hu Y; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.
    De Jager V; van der Merwe L; Venter A; Donald PR; Diacon AH
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.
    Murugasu-Oei B; Dick T
    J Antimicrob Chemother; 2000 Dec; 46(6):917-9. PubMed ID: 11102410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical significance of the quantity of tubercle bacilli in the sputum during tuberculostatic treatment. II. The effect of 2 and 3-drug combinations on the tempo of decrease of the quantity of bacteria].
    Seri I
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 Dec; 131(5):368-74. PubMed ID: 4957553
    [No Abstract]   [Full Text] [Related]  

  • 33. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.
    Sirgel FA; Donald PR; Odhiambo J; Githui W; Umapathy KC; Paramasivan CN; Tam CM; Kam KM; Lam CW; Sole KM; Mitchison DA
    J Antimicrob Chemother; 2000 Jun; 45(6):859-70. PubMed ID: 10837441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of common antiseptics against multidrug-resistant Mycobacterium tuberculosis.
    Rikimaru T; Kondo M; Kajimura K; Hashimoto K; Oyamada K; Miyazaki S; Sagawa K; Aizawa H; Oizumi K
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):763-70. PubMed ID: 12234131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 37. Bactericidal activities of commonly used antiseptics against multidrug-resistant mycobacterium tuberculosis.
    Rikimaru T; Kondo M; Kajimura K; Hashimoto K; Oyamada K; Sagawa K; Tanoue S; Oizumi K
    Dermatology; 2002; 204 Suppl 1():15-20. PubMed ID: 12011515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of disinfectants and heat against Escherichia coli O157:H7.
    Oie S; Kamiya A; Tomita M; Katayama A; Iwasaki A; Miyamura S
    Microbios; 1999; 98(389):7-14. PubMed ID: 10413874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.
    Walter ND; Dolganov GM; Garcia BJ; Worodria W; Andama A; Musisi E; Ayakaka I; Van TT; Voskuil MI; de Jong BC; Davidson RM; Fingerlin TE; Kechris K; Palmer C; Nahid P; Daley CL; Geraci M; Huang L; Cattamanchi A; Strong M; Schoolnik GK; Davis JL
    J Infect Dis; 2015 Sep; 212(6):990-8. PubMed ID: 25762787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of ethanol against glucose nonfermentative Gram-negative bacilli.
    Koshiro A; Oie S
    Microbios; 1984; 40(159):33-40. PubMed ID: 6727697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.